Read the latest articles, press releases, blogs and other media involving Psilos and our Portfolio Companies

Gamma Medica and Alpha Imaging Partner and Sign Distribution Agreement

By | NEWS | No Comments

Expanding the reach of Molecular Breast Imaging; a new standard of care in early breast cancer detection

WILLOUGHBY, OH and SALEM, NH – January 6, 2016 – Alpha Imaging, one of the largest independent sales and service providers of advanced medical imaging equipment, today announced that it has executed a distribution agreement with Gamma Medica, Inc. The agreement covers distribution of Gamma Medica’s LumaGEM Molecular Breast Imaging solution in the Midwest and Mid-Atlantic regions. Read More

Psilos VC: Digital Health Will Emerge as Top Performer in 2016

By | NEWS | No Comments

As 2015 winds down, it’s a good time to look into the crystal ball for one of the toughest industries to predict: healthcare.

We recently picked the brain of David Eichler, a managing partner with New York-based venture capital firm Psilos Group. Eichler (pictured) focuses on investments in digital health and medical device companies, and he currently is the board chair of Gamma Medica and Caregiver Services. Read More

Pink is The New Black; The Health Care Blog Op Ed by David Eichler

By | NEWS | No Comments

Pink is the new black this October, which marks the 30th anniversary of National Breast Cancer Awareness Month. NFL players are clad in bright pink shoes and wrist bands. American Airlines employees are wearing pink uniform accents and serving complimentary pink lemonade. Police departments across the country are patrolling in pink cruisers. It’s all for a great cause. The money and awareness raised through this campaign helps to fight an insidious disease that will kill more than 40,000 women in the U.S. this year. Read More

Marshfield Clinic Health System, Gamma Medica Partner to Create World’s First Mobile Molecular Breast Imaging Unit

By | NEWS | No Comments

Women throughout Wisconsin will now have access to a new standard of care in early breast cancer detection

MARSHFIELD, WI and SALEM, NH – October 27, 2015 – Marshfield Clinic Health System (MCHS) and Gamma Medica, Inc., today announced their partnership to install the LumaGEM® Molecular Breast Imaging (MBI) system on a new mobile medical unit, creating the world’s first mobile MBI service. Read More

Gamma Medica Receives CE Mark for LumaGEM® Molecular Breast Imaging System, a New Standard of Care in Breast Imaging

By | NEWS | No Comments

SALEM, N.H, – October 12, 2015 – Gamma Medica, Inc., a breast imaging medical device company, today announced the CE Mark approval allowing for the sale and distribution of the LumaGEM® Molecular Breast Imaging (MBI) system within the European Economic Area (EEA). Gamma Medica is finalizing distribution partners in strategic markets across the EEA. Read More

Breaking Health Podcast: Hosted by Stephen Krupa

By | NEWS | No Comments

Norwest Venture Partners General Partner Robert Mittendorff, MD, and Breaking Health Host Steve Krupa of Psilos Group bring their considerable experiences to bear. Krupa delves into Mittendorff’s ability to balance practicing medicine with identifying game-changing new digital health technologies for one of the leading investors in digital health. Mittendorff also discusses the highlights he sees in the coming Digital Healthcare Innovation Summit including Digital Therapeutics, Population Health, and the Rise of the Consumer. Read More

Breakthrough Mayo Clinic Study Highlights MBI Secondary Screening Technology as a Cost-Effective Way to Increase Accurate Breast Cancer Diagnoses

By | NEWS | No Comments

A recent study conducted by Mayo Clinic has determined that the addition of Molecular Breast Imaging (MBI) for women with dense breast tissue resulted in a lower cost per cancer detected than screening with mammography alone. The study, published in the American Journal of Roentgenology (AJR), entitled,Diagnostic Workup and Costs of a Single Supplemental Molecular Breast Imaging Screen of Mammographically Dense Breasts,” found MBI technologies led to more accurate diagnosis rates, and in combination with mammography, resulted in a cost savings of approximately 15 percent. Read More